Emergent BioSolutions (EBS) Cost of Revenue (2011 - 2026)
Emergent BioSolutions (EBS) posted Cost of Revenue of $97.1 million for Q2 2026, up 45.1% from $66.9 million a year earlier and up 34.9% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Cost of Revenue (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Emergent BioSolutions was $339.9 million, down 14.2% year-over-year; for FY2025, it came in at $326.2 million, down 52.1% from FY2024.
- Annual Cost of Revenue shows a five-year compound annual growth rate of -9.5% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Cost of Revenue was $681.3 million in FY2024 (-3.4%), $705.4 million in FY2023 (+1.8%), $693.1 million in FY2022 (-7.4%) and $748.1 million in FY2021 (+39.3%).
- The Q2 2026 figure stands as the highest quarterly Cost of Revenue since Q4 2024.
- On a year-over-year basis, Cost of Revenue increased in 1 of the last eight quarters, with an average decline of 26.8%.
- The strongest year-over-year quarter for Cost of Revenue in the past five years was Q1 2022, with growth of 57.0%; the weakest was Q2 2025, with a decline of 77.4%.
- According to Business Quant data, Cost of Revenue for the three prior quarters was $72 million (Q1 2026), $84.9 million (Q4 2025) and $85.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Emergent BioSolutions | 320.11 Mn | -430.79 Mn | 137.20 Mn | 97.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 97.10 Mn |
| Mar 31, 2026 | 72.00 Mn |
| Dec 31, 2025 | 84.90 Mn |
| Sep 30, 2025 | 85.90 Mn |
| Jun 30, 2025 | 66.90 Mn |
| Mar 31, 2025 | 88.50 Mn |
| Dec 31, 2024 | 118.00 Mn |
| Sep 30, 2024 | 122.60 Mn |
| Jun 30, 2024 | 296.10 Mn |
| Mar 31, 2024 | 144.60 Mn |
| Dec 31, 2023 | 185.10 Mn |
| Sep 30, 2023 | 176.80 Mn |
| Jun 30, 2023 | 190.60 Mn |
| Mar 31, 2023 | 152.90 Mn |
| Dec 31, 2022 | 220.50 Mn |
| Sep 30, 2022 | 147.20 Mn |
| Jun 30, 2022 | 169.80 Mn |
| Mar 31, 2022 | 155.90 Mn |
| Dec 31, 2021 | 203.50 Mn |
| Sep 30, 2021 | 181.80 Mn |
API Access
Emergent BioSolutions Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();